Drugs / AMAP102
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00995605 | Apr → Aug 2009 | — | AnaMar AB | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMAP102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00995605 ↗ |
| Route | Oral | “Multiple Oral Dose” NCT00995605 ↗ |